# Single-dose DSS-induced inflammation enhances colorectal tumorigenesis in APC and KRAS mutant mice

**Authors:** Kazuki Ishibashi, Yuji Urabe, Takahiro Uda, Yukiko Sako, Tomoyuki Gurita, Satoshi Masuda, Yoshiki Hatsushika, Takeo Nakamura, Hirona Konishi, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yoshihiro Kishida, Yuichi Hiyama, Hidehiko Takigawa, Toshio Kuwai, Hiroaki Niitsu, Takao Hinoi, Shiro Oka

PMC · DOI: 10.1038/s41598-025-25577-1 · Scientific Reports · 2025-11-24

## TL;DR

Mild inflammation boosts colorectal tumor growth in mice with APC and KRAS mutations, highlighting inflammation's role in cancer development.

## Contribution

Demonstrates that transient inflammation promotes tumorigenesis in APC and KRAS mutant mice, a novel insight into CRC progression.

## Key findings

- DSS-treated APC; KRAS mutant mice developed more and larger tumors in the proximal colon.
- DSS-induced inflammation did not affect tumor-free KRAS mutant mice but increased tumors in APC mutants.
- Elevated regulatory T cells and M2 macrophages suggest an immunosuppressive tumor microenvironment in APC; KRAS mutants.

## Abstract

Colorectal cancer (CRC) arises through interactions between driver mutations, such as in APC and KRAS, and the tumor microenvironment (TME), including inflammatory factors. While chronic inflammation is a known risk factor, the role of transient mild inflammation in tumorigenesis remains unclear. This study assessed the impact of mild inflammation on CRC development using genetically modified KRAS mutant (mut), APC mut, and APC; KRAS double mut mouse models. Mice received tamoxifen at six weeks and were evaluated with or without a 5-day administration of 1.5% dextran sulfate sodium (DSS). Mice were sacrificed at 20 weeks, and tumor number, size, location, histology, immunofluorescence, and RNA sequencing were analyzed. Tumors were absent in APC and KRAS mut mice not treated with DSS, while APC; KRAS mut mice developed small proximal colon tumors. DSS-treated KRAS mut mice remained tumor-free, but APC and APC; KRAS mut mice developed multiple tumors throughout the colon. In APC; KRAS mut mice, DSS significantly increased tumor number and size in the proximal colon. Although DSS did not alter immune infiltration in proximal tumors, regulatory T cells and M2 macrophages were elevated in APC; KRAS compared to APC mutants, suggesting immunosuppressive TME. These findings indicate that transient inflammation promotes CRC development in APC mutant mice.

The online version contains supplementary material available at 10.1038/s41598-025-25577-1.

## Linked entities

- **Genes:** APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845]
- **Chemicals:** tamoxifen (PubChem CID 2733526)
- **Diseases:** colorectal cancer (MONDO:0005575)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}
- **Diseases:** tumorigenesis (MESH:D063646), Tumors (MESH:D009369), CRC (MESH:D015179), chronic (MESH:D002908), colon tumors (MESH:D003110), inflammation (MESH:D007249)
- **Chemicals:** DSS (MESH:D016264), tamoxifen (MESH:D013629)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12644814/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12644814/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12644814/full.md

---
Source: https://tomesphere.com/paper/PMC12644814